Enterprise Solutions

  1. CryoVault™ Freeze & Thaw Platform Brochure
    9/16/2019

    CryoVault™ is a scalable, robust, completely single-use freeze and thaw platform for biopharmaceuticals. This end-to-end solution provides the industry leading implementation of this demanding unit processing operation.

  2. CryoVault™ Freeze & Thaw Platform
    9/16/2019

    CryoVault™ is a scalable, robust, completely single-use freeze and thaw platform for biopharmaceuticals.

  3. Rosemount™ Liquid Analytical Sensors For Single-Use Bioreactors In Biopharmaceutical Manufacturing
    8/28/2019

    It’s difficult to find reliable, efficient single-use liquid sensor technologies that overcome current measurement challenges necessary for maintaining product quality while meeting process development schedules. Read how The Rosemount's single-use sensors provide the same proven stability and performance as traditional stainless steel technologies and are uniquely adapted to fully meet the needs of the single-use biopharmaceutical manufacturing environment.

  4. Single-Use Dissolved Oxygen Sensor Adapter: 550DW Datasheet
    8/12/2019

    Rosemount 550DW single-use dissolved oxygen sensor adapter is compatible with standard stainless-steel DO sensors, currently validated with the Rosemount Hx438, and enables placement into the bioreactor single-use bag. Only the gamma-irradiated adapter touches the process solution, meaning the sensor can be reused for multiple batches. The sensor can be air-calibrated prior to start-up to verify functionality with no fill product needed in the bioreactor. Shelf life is two years.

  5. Single-Use pH Sensors For Bioprocessing Applications: 550pH Datasheet
    8/12/2019

    Rosemount 550pH sensor is designed to provide high measurement stability for single-use bioprocessing applications. The sensor stability of <0.005 pH change per day enables users to do a one-point calibration at the start of the batch and operate for 30-days without any required maintenance or recalibration. The unique capability of being stored wet significantly increases shelf life to two years and allows immediate verification and calibration eliminating the initial stabilization process.

  6. Single-Use pH Sensors For Bioprocessing Applications: 550pH
    8/12/2019

    Rosemount 550pH sensor is designed to provide high measurement stability for single-use bioprocessing applications. The sensor stability of <0.005 pH change per day enables users to do a one-point calibration at the start of the batch and operate for 30-days without any required maintenance or recalibration. The unique capability of being stored wet significantly increases shelf life to two years and allows immediate verification and calibration eliminating the initial stabilization process.

  7. Single-Use Dissolved Oxygen Sensor Adapter: 550DW
    8/12/2019

    Rosemount 550DW single-use dissolved oxygen sensor adapter is compatible with standard stainless-steel DO sensors, currently validated with the Rosemount Hx438, and enables placement into the bioreactor single-use bag. Only the gamma-irradiated adapter touches the process solution, meaning the sensor can be reused for multiple batches. The sensor can be air-calibrated prior to start-up to verify functionality with no fill product needed in the bioreactor. Shelf life is two years.

  8. Samsung Biologics: A CDMO Delivering Innovation And Capacity
    6/28/2019

    Samsung Biologics is a fully integrated CDMO with the largest capacity in the world. The company provides development and manufacturing services for biopharma companies of any size and delivers superior client satisfaction through execution excellence and innovation.

  9. Ibex™ Develop
    6/13/2019

    The efficacy and safety of biopharmaceutical products, combined with their ability to address previously untreatable conditions is driving strong demand. Concurrently, to accelerate access to life-changing medicines, the number of breakthrough therapies and fast track designations are increasing, shortening drug development timelines considerably.

  10. Ibex™ Dedicate
    6/13/2019

    As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.